Amlodipine Besylate Tablet
Product Images NDC 72789-515

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 72789-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789514 Label (72789514)

Label for Amlodipine Besylate tablets, USP 2.5 mg from PD-Rx Pharmaceuticals, Inc., featuring a package size of 1000 tablets. The label includes dosage form as tablets for oral use, storage instructions at 20° to 25°C, and directs product inquiries to the manufacturer in Oklahoma City, OK.*

FDA Label Image

72789515 Label (72789515)

Label for Amlodipine Besylate Tablets USP 5 mg, containing 1000 tablets. The label shows the NDC 72789-515-95 and states the product is for prescription use only. It includes storage instructions, manufacturer contact information for PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and advises dispensing with a patient information sheet.*

FDA Label Image

72789516 Label (72789516)

Label for Amlodipine Besylate Tablets, USP 10 mg, containing 1000 tablets by PD-Rx Pharmaceuticals, Inc. It includes the NDC number 72789-516-95, storage instructions, dispensing information, a barcode, and contact details for the manufacturer. The label also directs to prescribing information via a QR code.*

FDA Label Image

Chemstruc (Chemstruc)

Chemical structure of amlodipine besylate shown with molecular formula C6H6O3S indicated. The structure includes rings, chlorine, oxygen, nitrogen, and alkyl functional groups.*

FDA Label Image

Fig1 (Fig1)

A Kaplan-Meier curve graph comparing event rates over time (months) between Amlodipine and placebo groups. The x-axis shows time in months up to 24, and the y-axis shows event rate from 0 to 0.25. Two lines represent the event rates for placebo and Amlodipine groups, with the placebo line consistently higher. A summary box includes a P-value of 0.003, hazard ratio of 0.691, and 95% confidence interval of 0.54 to 0.88.*

FDA Label Image

Fig2 (Fig2)

A forest plot displaying hazard ratios with 95% confidence intervals comparing Amlodipine Besylate to placebo in various patient subgroups. The x-axis shows hazard ratios from 0.0 to 2.0, with the vertical line at 1.0 indicating no difference. Subgroups include overall patients, age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. Most hazard ratios favor Amlodipine Besylate over placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.